March 01
Anjum Shabbir
9th January 2020
Competition & State Aid

Acquisition of Columbia Asia Healthcare by TPG & Hong Leong Group

The Commission received prior notification of a concentration concerning the acquisition of shares by TPG (United States) and Hong Leong Group (Malaysia) of Columbia Asia Healthcare (Singapore) on 18 November 2019, under Article 4 of Merger Regulation No 139/2004. On 10 December 2019, the Commission decided that there was no concentration due to a finding that there would be very limited impact on the market, based on Article 6(1)(b) of that same Regulation.

Click here to see today’s brief publication of that decision 2020/C 5/01 in the Official Journal, and here for the Commission’s press release of 11 December 2019.


Your privacy is important for us

We use cookies to improve the user experience. Please review privacy preferences.

Accept all Settings

Check our privacy policy and cookies policy.